A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer

NCT01194427 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Difficulty meeting patient accrual goals

Conditions

Stage I Breast Cancer
Stage II Breast Cancer
Stage III Breast Cancer
Invasive Breast Cancer

Interventions

DRUG: Vorinostat and Tamoxifen

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]